Health
Study: More investment is needed to produce, distribute approved COVID-19 vaccines – News-Medical.Net
The success of a COVID-19 vaccine will depend not only on its efficacy but will hinge at least as much on how fast and widely it can be delivered, the severity…
Reviewed by Emily Henderson, B.Sc.Nov 20 2020
The success of a COVID-19 vaccine will depend not only on its efficacy but will hinge at least as much on how fast and widely it can be delivered, the severity of the pandemic, and the public’s willingness to be immunized, according to a study published in Health Affairs.
The authors, who include investigator and senior author Rochelle Walensky, MD, MPH, chief of the Division of Infectious Diseases at Massachusetts General Hospital (MGH), demonstrate…
-
Business19 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business18 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News15 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business15 hours ago1 ASX dividend stock down 43% I’d buy right now